Authored by Zachary Stieber via The Epoch Times,
The federal government is slated to invest millions to develop treatment with ibogaine, a psychedelic drug, Health Secretary Robert F. Kennedy Jr. said on Nov. 12.
The Advanced Research Projects Agency for Health, part of Kennedy's agency, is investing up to $4.9 million to lay the groundwork for regulatory and manufacturing needs for future ibogaine clinical trials, rather than directly funding trials.
Veterans and Americans struggling with serious mental illness deserve new hope and better treatment options.
HHS and @ARPA_H are investing up to $4.9M to advance ibogaine research for PTSD, alongside a new $20M funding opportunity to study rapid-acting treatments like ketamine,... pic.twitter.com/FhzyITfBJu— HHS (@HHSGov) November 12, 2026
Ibogaine is illegal in the United States, but President Donald Trump signed an executive order in April that directed agencies to open up access to it and some othe
